Like cetuximab, in addition, it inhibits the binding of ligands towards the EGFR and following downstream cell signalling pathways nonetheless it does not have any ADCC and CDC features [86]
Like cetuximab, in addition, it inhibits the binding of ligands towards the EGFR and following downstream cell signalling pathways nonetheless it does not have any ADCC and CDC features [86].…